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Abstract: Carrots are consumed worldwide. Several meta-analysis studies on carrot consumption
have indicated that carrots play a central role as a protecting vegetable against development of
different types of cancers. A cancer-preventive role of carrots is plausible because they are the main
dietary source of the bioactive polyacetylenic oxylipins falcarinol (FaOH) and falcarindiol (FaDOH),
which have shown anti-proliferative and anti-inflammatory activity in numerous in vitro studies. In
addition, purified FaOH and FaDOH have, in recent studies in colorectal cancer (CRC)-primed rats,
demonstrated an anti-neoplastic effect in a dose-dependent manner. The mechanisms of action for
this effect appears to be due to inhibition of pro-inflammatory and transcription factor biomarkers for
inflammation and cancer. However, studies of the CRC-preventive effect of carrots in a large cohort
are still missing. We therefore examined the risk of being diagnosed with CRC as predicted by intake
of carrots in a Danish population of 57,053 individuals with a long follow-up. Self-reported intake of
raw carrots at a baseline of 2–4 carrots or more each week (>32 g/day) was associated with a 17%
decrease in risk of CRC with a mean follow-up of >18 years, compared to individuals with no intake
of raw carrots even after extensive model adjustments (HR 0.83 CI 95% 0.71; 0.98). An intake below
2–4 carrots each week (<32 g/day) was not significantly associated with reduced risk of CRC (HR
0.93 CI 95% 0.82; 1.06). The results of this prospective cohort study clearly support the results from
studies in cancer-primed rats for CRC and hence a CRC-preventive effect of carrots.
Keywords: carrots; apiaceous vegetables; colorectal cancer; risk; cohort study
1. Introduction
The cancer-preventive effects of fruit and vegetables have been intensively studied for over
30 years. According to early epidemiological research, there is an inverse association between the
intake of fruit and vegetables and the risk of developing cancers [1–3]; however, recent epidemiological
studies indicate that for common cancers such as breast, colorectal, lung and prostate cancer, small or
no association between total fruit and vegetable consumption and cancer risk exists [4,5]. In early
studies, the cancer-preventive effects of fruit and vegetables were mainly ascribed to their content
of minerals, fibers and antioxidants. However, fruit and vegetables have very varied composition
of nutrients and other constituents, and therefore it is still possible that there are cancer-preventive
effects to be identified for the intake of individual fruit and vegetables. In particular, vegetables contain
a wide variety of compounds with many interesting bioactivities that are unrelated to antioxidant
effects. Some of these bioactive constituents may contribute to the potential cancer-preventive effects
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of vegetables and thus may help to obtain a deeper understanding of their health promoting effects in
general [6–8]. This is, for example, the case if we look at apiaceous vegetables such as carrots that are
consumed worldwide and in particular in North America and in European countries.
Carrots are rich in carotenoid antioxidants such as β-and α-carotene and epidemiological studies
have shown that a high content of β-carotene in the blood is correlated with a low incidence of cancers
and other diseases [9–11]. In most European countries and North America, more than 50% of the
β-carotene intake is provided by carrots, although in these regions of the world, carrot consumption is
better correlated with the intake of α-carotene [12]. Several studies have also found stronger negative
correlations of developing cancer and in particular lung cancer with intake of α-carotene rather
than β-carotene [13,14]. Thus, it is widely accepted that carrots play a central role as a protecting
vegetable against development of cancer, which is supported by recent meta-analysis studies on carrot
consumption in relation to the development of breast, gastric, lung and prostate cancer [15–18]. The
cancer-preventive effect of this vegetable has mainly been explained by its high contents of carotenoids;
however, intervention studies have shown that supplementation with carotenoids does not protect
against development of this disease [10,11,19]. Hence, α-carotene and β-carotene may be biomarkers
for the intake of other bioactive constituents in carrots with cancer-preventive effects. Such potential
anticancer compounds are indeed present in carrots and includes mainly phenylpropanoids [20] and
polyacetylenic oxylipins [21–28] of which the latter type of bioactive constituents are the most studied
both in vitro and in vivo.
The major polyacetylenic oxylipins in carrots are falcarinol (FaOH) and falcarindiol (FaDOH) and
carrots are the major dietary source of this type of bioactive compounds, although they are also present
in other apiaceous vegetables such as celery, celeriac, fennel, and parsley [28–30]. FaOH and FaDOH
have received considerable attention in recent years due to their cytotoxic and anti-inflammatory
activities in vitro [21,24–26,29–34] and, recently, the anti-neoplastic effects of these polyacetylenic
oxylipins have been demonstrated in cancer-primed rat models for colorectal cancer (CRC) [21,23,27].
CRC is the third cause of cancer-related death in developed countries and is probably associated
with a modern lifestyle typified by limited physical activity, alcohol consumption and dietary
changes [35,36]. CRC is a metastatic type of cancer that is developed in a multistep process,
from normal epithelial cells via inflammation to aberrant crypt foci and progressive adenoma stages,
to carcinomas [37,38]. To reduce the incidence and consequences of CRC, effective prevention
and treatment strategies need to be identified. Due to the long precancerous stage of this disease,
dietary intervention may exert favorable effects on polyp formation and/or inhibition of adenomas
transformation to CRC. Recent findings indicate that long-term consumption of a diet rich in vegetables
may prevent the development of CRC [39,40]. Chronic inflammation appears to play key role in
the development of CRC. Cyclooxygenase 2 (COX-2) levels are low in normal tissue but are rapidly
induced as an early response to growth factors, cytokines and tumor promoters associated with
inflammation, abnormal proliferation, angiogenesis, invasion, and metastasis, and the existence of
an association between CRC and COX-2 overexpression appears to be established [41–43]. Studies
on the anti-neoplastic effects of FaOH and FaDOH in tumors of cancer-primed rats for CRC have
demonstrated that these polyacetylenic oxylipins inhibit pro-inflammatory and transcription factor
biomarkers for inflammation and cancer such as COX-2, interleukin 6 (IL-6), tumor necrosis factor alfa
(TNF-α) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [21]. Hence, carrots
contain bioactive compounds that target CRC development and thus carrot intake could be one of the
most important dietary measures for the prevention of CRC. Polyacetylenic oxylipins are, however,
sensitive to heat, light and oxidation, and previous investigations of blanched or cooked carrots
have shown that the content of these bioactive compounds may be reduced up to 70% by thermal
processing [44,45]. Furthermore, carrot juice represents another source of polyacetylenic oxylipins,
but the content of these bioactive compounds is also reduced in carrot juice compared to raw carrots
due to their low water solubility and possible thermal treatment as well as pH of the carrot juice [46].
On the other hand, the availability of these compounds may be increased in processed vegetables due
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to alteration of the structure and digestibility of the food thus increasing their bioavailability, which to
some extent can offset the cancer-preventive effect of raw versus processed carrots. This is consistent
with the fact that no major differences in the cancer-preventive effects of raw versus cooked vegetables,
including carrots, have been observed [47].
However, more specific studies of the effect in a human population are still missing in order to
conclude whether carrot intake reduces risk of CRC and what quantity of carrot intake is sufficient.
The aim of this study was to investigate the risk of being diagnosed with CRC as predicted by intake of
carrots in a large Danish study population with a long follow-up.
2. Materials and Methods
2.1. Study Population
This study was conducted as a prospective cohort study investigating risk of CRC in individuals
originally included in the Diet, Cancer and Health study [48]. Follow-up was conducted using Danish
National Registers (described in detail below).
In total, 160,725 individuals aged from 50 to 64, who were born in Denmark, with residence in
the area of Aarhus or Copenhagen and had no previous cancer diagnose registered were invited for
participation. Inclusion for the Diet, Cancer and Health cohort was initiated in 1993 and ended by 1997.
Individuals received written information and invitation. In case of non-responders, reminders were
distributed three weeks past initial invitation. After an additional three weeks with no response, a new
invitation letter was sent. A validated 192 item food frequency questionnaire was filled out by the
participants on their consumption of categorized food and beverages during the last 12 months [48–50].
Further, the individuals filled in a lifestyle questionnaire collecting data on known cancer risk factors
including history of smoking, alcohol, physical activity, previous illness, education and occupation. A
lab technician conducted measurements of height and weight on each participating individual [48].
Individuals were followed until 31st of December 2016 or until they were diagnosed with CRC, died or
emigrated (and thereby lost for follow-up).
2.2. Data from Registries
The Danish Civil Registration System held information on the personal identification number
of all individuals with permanent residence in Denmark, as well as dates of migration and dates of
death [51]. This made it possible to follow each individual in the National registers in this study. The
Danish Cancer Registry records all incidences of malignant neoplasms and some precancerous and
benign lesions in the Danish population [52] and was used to identify CRC diagnoses.
2.3. Exposure
As carrots are the major dietary source of the bioactive compounds of interest, they were the
main exposure in this study. Embedded in the food frequency questionnaire were items regarding
raw carrot intake, carrot juice intake and prepared/cooked carrots. As the levels of FaOH and FaDOH
decreases significantly when carrots are blanched or cooked, thermal processed carrots are of lesser
interest than raw in relation to cancer-preventive measures. The same is the case for carrot juice as
described in the introduction. Therefore, raw carrot was chosen as the main exposure, but carrot juice
and thermal processed carrots were included in sensitivity analyses. Participants reported frequency
of intake ranging from never to 8 or more times per day. Using standard portion sizes, the daily intake
in grams was then calculated using FoodCalc [53]. This resulted in 11 different possible values of
intake in grams per day (g/day) per individual ranging from 0 to 487.5 g per day. The dose of FaOH
and FaDOH needed to identify potential risk reductions in CRC development is unknown. However,
recent studies on the effect of FaOH and FaDOH on precursor lesions of CRC in azoymethane-induced
rats indicate that a cancer-preventive effect in humans may be obtained with an intake of more than
2.5 mg of each polyacetylene per day [21,23]. The content of FaOH and FaDOH varies considerably
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between carrot genotypes [45,54,55] but based on the results from the CRC-primed rat studies, it is
estimated that the intake of raw carrots should be at least between 30 and 100 g per day to obtain a
cancer-preventive dose of polyacetylenes. Although, the cancer preventing effect of FaOH and FaDOH
previously seen in rats was a logarithmic dose-response effect [21], it is assumed that the intake of
carrots will result in a non-linear effect due to variability in the concentration of these polyacetylenes
in different commercially available carrot genotypes. Thus, the exposure variable should be treated
categorically. Based on this information and after investigating the distribution of raw carrot intake
in the study population and the incidence of CRC in each of the 11 possible g/day groups, a further
categorization of no raw carrot intake, less than 32 g/day and more than 32 g/day was performed.
2.4. Outcome
Outcome was defined as any CRC diagnosis. CRC diagnoses were identified by ICD-10 codes in
the registries. ICD-10 codes identified as CRC were C180–189, C199 and C209.
2.5. Covariates
Gender and age were included in model II. Age was divided into three groups of 50–54, 55–59
and 60–65 years of age. Previous cerebral or coronary artery thrombosis and intake of nonsteroidal
anti-inflammatory drugs (NSAIDs) were included in model III as dichotomous variables created from
self-reported answers to the lifestyle questionnaire. Smoking, alcohol intake, body mass index (BMI)
and metabolic equivalents (MET) score were included in model IV and were based on self-reported
answers from the lifestyle questionnaire except for BMI, which was calculated based on height and
weight, which was measured by a lab technician at baseline and categorized as low (<18.5), normal
(18.5–25) and high (>25). Smoking was categorized as non-smoker, former smoker and current smoker.
Alcohol intake was categorized as no alcohol intake, intake within current recommendations and intake
over the current recommendations. Danish low risk recommendations were at the time of collecting
the data from the study population no more than 14 units per week for women and no more than 21
units per week for men but today the recommendations have been changed to <7 units for women
and <14 units for men [56]. MET score was calculated from self-reported activity levels in lifestyle
questionnaire and categorized as quartiles in the study population. Intake of other root vegetables
(celery, ginger root and part frozen carrot from vegetable mix) and intake of all other vegetables (not
including root vegetables or carrots) were included in model V and was derived from food frequency
questionnaire. Other root vegetables and all other vegetables were categorized as quartiles of intake in
the study population.
2.6. Ethics
The Diet, Cancer and Health study was originally approved by the relevant scientific committees
and the Danish data protection agency. Individual informed consent was obtained from each participant
in order to link cohort data with information from national registers [48]. Only aggregated anonymized
analyses and results are published in the current study.
2.7. Statistical Analysis
X2-tests were used to compare baseline characteristics. Cumulative incidence proportion curves of
CRC diagnoses were created, in which individuals who died or emigrated were censored. As inclusion
for the study was done in a period longer than four years, the possible follow-up time varied between
individuals. Cumulative incidence proportion curves were therefor limited to 7157 days, which was
the shortest possible observation time for individuals alive in Denmark with no CRC diagnosis
by 31st December 2016 (from last inclusion day until 31st of December 2016). Cox proportional
hazard regression models were conducted testing the correlations between raw carrot intake and
incidence of CRC. Model I was a univariate regression model and model II–V were multivariate
models, increasingly adjusting for other factors. Other root vegetables and vegetables in general
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were included in the regression models as covariates to isolate the effect of carrots. Demographic
characteristics, lifestyle habits and intake of medication influencing the COX-2 activity were included
as covariates in the models as well. Tests for interactions between main exposure variable and each of
the included covariates in the full model were conducted. Sensitivity analyses investigating carrot
juice, processed carrots and total carrot intake (raw, processed and juice combined) as exposures
were also conducted. Sensitivity analysis was conducted using age as time, comparing individuals
of the same age instead of adjusting for age group at entry as a covariate in the regression models.
Schoenfeld residuals were examined to verify the proportional hazards assumption. Data management
was performed using SAS software version 9.4 (SAS Institute Inc. SAS 9.4. Cary, North Carolina, USA)
and statistical analyses were conducted using R statistical software package version 3.6.1 (R Core Team,
Vienna, Austria) (packages: Publish and Survival) [57–59].
3. Results
Out of 160,725 invited individuals, 57,053 participated in the Diet, Cancer and Health study.
In total, 585 individuals were excluded due to previous CRC diagnosis and 593 individuals were
excluded due to missing information for covariates. Complete information was obtained for 55,875
individuals who were eligible for analysis. In total, 1889 (3.38%) were diagnosed with CRC during
follow-up (Figure 1). Follow-up time varied from 3 to 8438 days, with a mean of 6845 days.
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calculated consumption higher than 32 g/day. The incidence of CRC was 3.9% for those eating no raw
carrots, 3.5% for those eating less than 32 g/day and 2.9% for those eating more than 32 g/day. X2-tests
showed significant differences in the incidence of CRC according to raw carrot intake, gender, age
groups, NSAID intake, BMI, and alcohol intake. No significant differences were seen according to
previous cerebral or coronary artery thrombosis, MET score, all other vegetable intake or intake of
other root vegetables (Table 1).
Table 1. Baseline characteristics of individuals with and in individuals without colorectal cancer (CRC)
incidence during follow-up, n = 55,875.
Variable Level CRC
a
n = 1889
No CRC
n= 53,986
Total
n = 55,875 p-Value
Raw carrot intake None 306 (3.9) a 7610 (96.1) b 7916
0–32 g/day 1105 (3.5) 30,440 (96.5) 31,545
Over 32 g/day 478 (2.9) 15,936 (97.1) 16,414 <0.001
Gender Female 857 (2.9) 28,373 (97.1) 29,230
Male 1032 (3.9) 25,613 (96.1) 26,645 <0.001
Smoking Non-smoker 586 (3.0) 18,993 (97.0) 19,579
Former smoker 603 (3.7) 15,513 (96.3) 16,116
Current smoker 700 (3.5) 19,480 (96.5) 20,180 <0.001
NSAID intake No 1347 (3.6) 36,311 (96.4) 37,658
Yes 542 (3.0) 17,675 (97.0) 18,217 <0.001
Body Mass Index Normal 717 (3.0) 23,386 (97.0) 24,103
Low 16 (3.4) 459 (96.6) 475
High 1156 (3.7) 30,141 (96.3) 31,297 <0.001
Previous cerebral or No 1830 (3.4) 52,278 (96.6) 54,108
coronary artery
thrombosis Yes 59 (3.3) 1708 (96.7) 1767 0.974
Alcohol intake Within recommendation 1006 (3.2) 30,918 (96.8) 31,924
No alcohol 41 (3.2) 1254 (96.8) 1295
Over recommendation 842 (3.7) 21,814 (96.3) 22,656 0.001
Age group 50–54 years 634 (2.7) 22,990 (97.3) 23,624
55–59 years 591 (3.4) 16,701 (96.6) 17,292
60–65 years 664 (4.4) 14,295 (95.6) 14,959 <0.001
Other root 1st quartile 478 (3.4) 13,457 (96.6) 13,935
vegetables 2nd quartile 486 (3.5) 13,481 (96.5) 13,967
3rd quartile 496 (3.5) 13,489 (96.5) 13,985
4th quartile 429 (3.1) 13,559 (96.9) 13,988 0.116
All other vegetables 1st quartile 485 (3.5) 13,444 (96.5) 13,929
2nd quartile 481 (3.4) 13,500 (96.6) 13,981
3rd quartile 466 (3.3) 13,491 (96.7) 13,957
4th quartile 457 (3.3) 13,551 (96.7) 14,008 0.738
METs—h/week 1st quartile 498 (3.5) 13,721 (96.5) 14,219
2nd quartile 467 (3.3) 13,783 (96.7) 14,250
3rd quartile 466 (3.4) 13,073 (96.6) 13,539
4th quartile 458 (3.3) 13,409 (96.7) 13,867 0.677
a CRC = Colorectal cancer b Values in parentheses are row percentages.
3.1. Comparison of High, Low and No Intake of Carrots
The cumulative incidence proportion of CRC was higher with a decreasing intake of raw carrots.
The cumulative incidence proportions increased throughout follow-up for all three exposure groups
(Figure 2).
The univariate cox proportional hazard regression model (model I) showed significant decreases
in risk of CRC in those with an intake less than 32 g/day (HR 0.82 CI95% 0.72; 0.93) and in those with an
intake over 32 g/day (HR 0.66 CI95% 0.57; 0.76), compared to those with no intake of raw carrots. After
adjusting for gender and age (model II) the risk differences were decreased and a significant difference
were only seen in subgroup eating more than 32 g/day (HR 0.79 CI95% 0.68; 0.91). The subsequent
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adjustments (model III through V) had only minimal effect on the risk estimates for raw carrot intake.
This resulted in a significant difference in risk for subgroup eating more than 32 g/day (HR 0.83 CI95%
0.71; 0.98), and an insignificant difference in risk for subgroup eating less than 32 g/day (HR 0.93 CI95%
0.82; 1.06), compared to subgroup eating no raw carrot, after full model adjustments (Figure 3).
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3.2. Sensitivity Analyses
Sensitivity analyses showed that carrot juice, prepared/cooked carrots or total carrot intakes were
not statistical significantly associated with incidence of CRC. Analyses of possible interactions between
raw carrot intake and each of the covariates from the model V did not identify any significant interactions.
Sensitivity analysis conducted using age as time resulted in similar HRs for raw carrot intake >32 g/day
as did the main analyses. Risks of CRC were statistically significant at 0.71, 0.80, 0.80, 0.85 and 0.84
respectively in model I through V for those with an intake >32 g/day compared to those eating no raw
carrot. Examination of Schoenfeld residuals verified the proportional hazards assumption.
4. Discussion
In this prospective cohort study, a population of 57,053 Danes was used to explore the association
between dietary carrot intake and risk of CRC. The results showed that high carrot intake corresponding
to >32 g raw carrot per day was associated with a 17% decreased risk of CRC, whereas an insignificant
difference in risk of CRC was observed for those eating less than 32 g raw carrot per day, compared to
those eating no raw carrot. To our knowledge, this is the first study evaluating the direct relationship
between carrot intake and the incidence of CRC, although in a previous study using data from two
case-control studies that included 1225 cases of CRC, it was shown that raw vegetables and in particular
raw carrots caused risk reductions of 20% for CRC [60]. A preventive role of carrot in the development
of CRC is plausible because carrots is the main dietary source of the bioactive polyacetylenic oxylipins
FaOH and FaDOH, which have demonstrated anti-proliferative effects in cancer cells [25,29] and
anti-neoplastic effects in CRC-primed rats in a dose-dependent relationship [21,23]. The preventive
role of FaOH and FaDOH in relation to CRC is probably linked to their alkylating properties leading
to covalent alkylation and inhibition of pro-inflammatory markers, enzymes, and inflammatory
transcription factors that play an important role in cancer development and in particular CRC [21,61].
According to the preclinical rat studies, a cancer-preventive dose of polyacetylenes can be obtained,
at an intake above 30 g of raw carrots per day, which furthermore substantiates the cancer-preventive
effects of carrots as demonstrated in this cohort study.
Based on the numerous in vitro studies on the anti-proliferative effects of FaOH and FaDOH on
cancer cells, it is clear that FaOH is more cytotoxic than FaDOH [21,25,29–31]. In addition, it has been
shown that FaOH inhibits in vitro, the growth of the human epithelial colorectal adeocarcinoma cell
line Caco-2, and that this effect is synergistically enhanced when combined with FaDOH [25]. In the
recent studies on the anti-neoplastic effects of FaOH and FaDOH in CRC-primed rats the ratio of these
polyacetylenes were 1:1 in the tested rat diets but other ratios may have resulted in even higher or lower
CRC-preventive effects [21,23]. Thus, not only the concentration of FaOH and FaDOH in carrots may
be important for the cancer-preventive effects of carrots but also the ratio between these polyacetylenes.
Factors that have an influence on the content of polyacetylenic oxylipins in consumed carrots,
includes besides processing as mentioned in the introduction also storage and location of cultivation
and not at least genotype. The cropping system on the other hand, i.e., organic versus non-organic
cultivation does not affect the content of these bioactive constituents [45,54]. Consequently, there
is a potential to optimize the content of polyacetylenic oxylipins in carrots and thus to increase the
possible cancer-preventive effect of carrots and carrot products. There are considerable differences in
the contents and ratio of FaOH and FaDOH between different carrot cultivars available in Denmark
and on the marked in general. This complicate the picture in relation to the preventive effect of carrot
intake on CRC but also show that there is a huge potential of optimizing the intake of FaOH and
FaDOH in selecting carrot cultivars for human consumption with an optimal composition profile
of these polyacetylenic oxylipins. Therefore, choosing the right carrot cultivar could increase the
preventive effect on CRC. Bitterness is considered as an undesirable taste of carrots, which is primarily
due to the content of FaDOH and di-caffeic acids that are mainly present in the peel and outer-layers
of carrots [62]. Therefore, raw carrots are usually peeled before intake. Peeling not only changes the
composition profile of FaOH and FaDOH of raw peeled carrots but also has an effect on the intake of
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these polyacetylenes because their concentration are higher in the peel per g fresh weight compared to
the rest of the carrot, and this is particular the case for FaDOH. Thus, an optimal CRC-preventive effect
of carrots not only depends on the cultivar but also how the carrots are processed before consumption.
Other apiaceous vegetables, such as celery, celeriac, fennel, parsley, and parsnip, do also contain
FaOH and FaDOH and for some of these vegetables the concentrations of FaOH and FaDOH in the
edible parts of these vegetables are even higher than in carrots [28,29]. However, these vegetables
seems not to contribute significantly to the overall intake of polyacetylenes mainly because they are
consumed in much lower quantities compared to carrots and because the root vegetables such as
celeriac and parsnip are often subjected to thermal processing resulting in considerably losses of
polyacetylenes as is the case for carrots. Intake of all other vegetables, including apiaceous vegetables,
were found not to have any significant impact on risk of CRC because no other root vegetables nor all
other vegetables were associated with incidence of CRC as demonstrated in model V (Figure 3). Hence,
previous studies reporting lower cancer incidence with higher vegetable intake, may partially be due
to the intake of carrots.
The study is based on self-reported 1 year recall of different food intakes and this is usually correlated
with some bias. First of all, the self-reported recall will result in some bias as participants will have
difficulties in remembering food intake as well as over-estimation of healthy food components [63,64].
Furthermore, carrot eaters may have a healthier behavior in general, although the adjustments for
MET, other vegetable intake, smoking and alcohol intake did not affect the hazard ratios notably.
If participants’ self-reported raw carrot intake is either randomly over- and underestimating actual
intake, or systematically overestimating, the decrease in risk of CRC correlated with raw carrot intake
is probably underestimated. Further, the true decrease in risk of developing CRC would probably be
even greater if the type and handling of carrots were controlled.
In the food frequency questionnaire, the participants reported intake of raw carrots per week and
in our study, effect on incidence of CRC was seen in intake as low as 2–4 carrots corresponding to >32
g raw carrot each day, i.e., half of a small-sized raw carrot each day. In the present study, the carrot
cultivars were not reported. However, if we look at the contents of polyacetylenes in an average carrot,
this will not give 24 h protection of the epithelial cells and so the effect of the carrots seems to be long
term. The halftime of FaOH and FaDOH has been shown to be approximately 5–6 h in the blood
circulation after intake of carrot juice [30,65,66].
Prepared/cooked carrots, carrot juice and total carrot intake were not statistical significantly
associated with incidence of CRC as expected even though this may increase the bioavailability of
bioactive polyacetylenic oxylipins. This is probably due to a great loss of FaOH and FaDOH in
preparation or preserving methods as described in the introduction.
Participants differed from non-participants, as the non-participants as a whole had a lower
socio-economic status than participants [48]. This would mean that the results may not be transferrable
to the general population, although the possibility of polyacetylenic oxylipins affecting socio-economic
strata in different ways is considered unlikely. This is also supported by the fact that no interactions
were found between raw carrot intake and any covariate, even though health-affecting behaviors are
often associated with socio-economic status.
5. Conclusions
Self-reported intake of raw carrot at a baseline of 2–4 carrots or more each week (>32 g/day)
was associated with a 17% decrease in risk of CRC, with a mean follow-up of more than 18 years,
compared to individuals with no intake of raw carrots even after extensive model adjustments.
An intake below 2–4 carrots each week (<32 g/day) was not significantly associated with risk of CRC.
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